v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 10,527 $ 8,259 $ 29,154 $ 22,864
General and administrative 3,972 3,292 11,402 9,018
Total operating expenses 14,499 11,551 40,556 31,882
Loss from operations (14,499) (11,551) (40,556) (31,882)
Interest income 37 262 138 1,081
Net loss $ (14,462) $ (11,289) $ (40,418) $ (30,801)
Net loss per common share, basic and diluted $ (0.28) $ (0.23) $ (0.78) $ (0.73)
Weighted-average shares used to compute net loss per common share, basic and diluted 52,048,563 49,999,239 51,674,063 41,964,042

Source